Healthcare
How to trade $JAN for max profit today.Hi traders, we have a trading idea to share with you.
The idea is for $JAN stock. The stock is currently above $ 4 (a support level) with upward momentum after reporting patent issuance for artery treatment.
In addition, the stock has a great upside if it will break through the trend line built on the 5-minute chart.
Bullish Swing Trade on UNHWith sell in May and go away in play. I thought I'd take a swing trade on UNH it is in a defensive sector(healthcare), which is a rotation method for the summer months. So I'll place a limit order @ 489.00 and a SL @ 454.00 and a TP @ 555.00. The order block and the market cycle (May 13 - Jun 6 2022) are confirmations.
ENDP - Potential Long SetupWe are tracking the close today for ENDP. If this stock has a strong close today with a daily RSI breakout, we may see a good 30-40% Retracement.
Few items we are tracking:
Daily RSI breakout at close
GAP to be filled withing next few weeks, or sooner. (Price targets included
30% - 40% Retracement
Let us know what you thing. Good luck all.
$HUM Humana LT Chart - LEAP OptionsHumana fairly rangebound for the last six months. Tested ~$470 key resistance level six times unsuccessfully. Monitor for a breakthrough and close above this level. Once this occurs we could see an overdue strong move to the $600 area by 1H of 2024.
Long Term Target: $580-$615 range by 1H '24
I plan to play this using LEAP options. I'm looking at the $450 and $500 Jan'24 calls. If you're looking to limit risk and capital outlay, I would consider a vertical call spread buying either the $450 or $500 call and selling the $600.
Note: This is NOT investment advice. This is opinion only.
4/24/22 UNHUnitedHealth Group Inc. ( NYSE:UNH )
Sector: Health Services (Managed Health Care)
Market Capitalization: $490.152B
Current Price: $520.94
Breakout price: $536.25
Buy Zone (Top/Bottom Range): $529.50-$507.55
Price Target: $548.50-$553.30 (1st), $611.50-$618.00 (2nd)
Estimated Duration to Target: 29-31d (1st), 97-100d (2nd)
Contract of Interest: $UNH 5/20/22 520c, $UNH 9/16/22
Trade price as of publish date: $18.57/contract, $25.25/contract
HCAT LongTechnical Analysis : We broke the downtrend line and had three white soldiers to confirm the reversal of the trend, also the falling wedge shows a bullish reversal since we broke it upwards. Although on a lower timeframe MACD and RSI look bearish, we expect the price to reach our Buy Zone before the impulsive move upwards.
Aroon : Aroon Up on Top and Aroon Down on bottom show a bullish momentum.
MACD : We had lower lows on the chart but not on MACD which shows MACD divergence and signals for a reverse of the downtrend.
Entry : 21.5-23.5
Target : 39.75 (at Fib50% and just below a previous high and resistance )
Invalidation : 19.5 ( Just Below our support and last low )
NVCR primed for an extended runKept the chart simple but there are a lot of bullish aspects at play here:
- ready for markup after an accumulation phase
- coming off a wave 5 correction apprx. 0.786 off the highs last June
- looking at weekly chart you’ll see a larger running flat structure
- earnings as a catalyst and overall great company!
*Initial Target by Apr 14 = 99
** Target range by 5/20/2022 = 108-116
Would love to hear your thoughts on this.
BNTX HIGH RISK TO REWARD SETUP YOU CAN'T MISSNews - Better than expected Q4 EPS and sales results, the company expects to authorize a shares repurchase program up to 1.5B over the next two years.
Levels -$195 is the next major resistance level.
$138 is the next major support level.
The stock is gapping up to $183 (pre-market).
The idea is to go long at the open when it will try to test the $183 support level and fail, then go long above the 5M bull flag pattern if it will happen.
3/20/22 REGNRegeneron Pharmaceuticals, Inc. ( NASDAQ:REGN )
Sector: Health Technology (Pharmaceuticals: Major)
Market Capitalization: $74.451B
Current Price: $685.94
Breakout price: $687.00
Buy Zone (Top/Bottom Range): $660.50-$603.40
Price Target: $812.00-$816.40
Estimated Duration to Target: 125-130d
Contract of Interest: $REGN 9/16/22 700c
Trade price as of publish date: $50.35/contract
3/13/22 LLYEli Lilly and Company ( NYSE:LLY )
Sector: Health Technology (Pharmaceuticals: Major)
Market Capitalization: $253.61B
Current Price: $266.30
Breakout price: $270.95 (hold above)
Buy Zone (Top/Bottom Range): $262.45-$247.10
Price Target: $308.00-$310.40
Estimated Duration to Target: 84-90d
Contract of Interest: $LLY 6/17/22 300c
Trade price as of publish date: $5.90/contract
Anthem, Inc. $ANTM flashing a VCPAnthem, Inc. is a provider of health insurance in the United States and is ranked 23rd on the Fortune 500. Fundamentals are very strong, it has an average YoY revenue growth of +14% for the las three quarters, and the last two quarters had EPS and Margin growth over the hundreds.
IBD is giving NYSE:ANTM a #1 rank in its industry group and a 94 relative strength rating. That is synonymous of good fundamentals accompanied by very good technicals. Relative to the NASDAQ, the index has done three lower lows as NYSE:ANTM has done three higher lows. That is the kind of action a future leader does.
Also, if you compare it against its sector AMEX:XLV , is doing way better.
For the las 5 weeks, the price has been making a classic VCP with a pivot buy above $472. Today had a bad close but with low volume, that is a good sign. But, as the market is still in a correction, breakouts aren't working very well. Is time to be cautios so, if the breakout happens I'll buy 1/4 of my typical position sizing.
an often mentioned healthcare stock (PFE)pfizer is one of those household names that has been getting constant attention since the outbreak of covid 19. right now it is at the tail end of a long downtrend, and healthcare is acting as a defensive play for risk off rotation. as long as the broader market bounces this should bounce.
Signify Health (NYSE: $SGFY) Boasts $773M Revenue Beats! 👩⚕️Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates in two segments, Home & Community Services and Episodes of Care Services. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers primarily under the Medicare Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. Its customers include health plans, governments, employers, health systems, and physician groups. The company was founded in 2017 and is headquartered in Dallas, Texas with additional offices in Austin, New York, Norwalk, and Rapid City.
$TLRY blue dream sniper 👁🗨*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
Today team purchased shares of marijuana company Tilray Brands $TLRY at $6.10 per share. Our take profit is $7 with a stop loss at $5.90.
Our Entry: $6.10
Take Profit: $7
Stop Loss: $5.90
If you want to see more, please like and follow us @SimplyShowMeTheMoney
$CAHRejected at the gap already. If we don't break into the grey area look for this stock to continue to pullback to the lower levels.
CHART LEGEND:
white dashed lines = bull/bear takeovers
blue lines = call targets
yellow lines = put targets
red line = danger zone
orange lines = trend lines
green lines = safe zone
any other lines add will be discussed with the ticker
NYSE:CAH